SIK2 inhibitors (Oncodesign)

N/A

Report date: 2025/01/26 16:58:21
NME

Base Information

Drug NameSIK2 inhibitors (Oncodesign)
Drug Alias Namesalt-inducible kinase 2 inhibitors (Oncodesign)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase SIK2 inhibitors
TargetsSerine/threonine-protein kinase SIK2
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAlgeria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncodesign Services
China Registration ClassN/A

Develop Information

Active CompaniesOncodesign Services
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A